The U.S. Food and Drug Administration (FDA) announced that it has approved Ultresa™ delayed-release capsules, a pancreatic enzyme replacement therapy. Ultresa (pancrelipase) is manufactured by Aptalis Pharma.
Site Search
Showing 61 - 64 of 64 results
News
|
|
1 min read
News
|
|
1 min read
Navigating CF is a series of short videos that help people with CF, their families, and care teams navigate complex issues. No matter where you are on your journey, Navigating CF can help.
The Foundation is here for you. Whether you're looking to talk to someone, find your local chapter or care center, or read some additional information, we have plenty of resources to help.